Search Within

Edmund King Bartlett

Formats
  1. Journal Article (35)
  2. Meeting Abstract (24)
  3. Review (6)
  4. Miscellaneous (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Guidelines (1)
Groups
  1. CTCR Scholars (78)
  2. MSK Grad Students (78)
  3. Master of Science in Clinical and Translational Cancer Research (78)
  4. Melanoma Disease Management Team (78)
  5. Surgery (78)
  6. Department of Medicine (41)

More Groups

People
  1. Charlotte Ariyan (25)
  2. Daniel Coit (23)
  3. Michael Marchetti (19)
  4. Danielle Bello (15)
  5. Mary Brady (14)
  6. Ciara Kelly (12)

More People

Years
  1. 2025 (6)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Annals of Surgical Oncology (27)
  2. Journal of the American College of Surgeons (8)
  3. JAMA Dermatology (5)
  4. Journal of Surgical Oncology (5)
  5. Journal of the American Academy of Dermatology (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. Springer (27)
  2. Elsevier Science, Inc. (8)
  3. Wiley Blackwell (8)
  4. American Medical Association (7)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Telomerase reverse transcriptase (TERT) promoter mutations are associated with higher tumor mutational burden and UV mutational signature in melanoma
    Meeting Abstract

    Leinwand, J. C.; Koh, E.; Bartlett, E.; Bello, D.; Brady, M. S.; Harding, J. J.; Morris, L.; Ariyan, C.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Population-based validation of the MIA and MSKCC tools for predicting sentinel lymph node status
    Journal Article

    Olofsson Bagge, R.; Mikiver, R.; Marchetti, M. A.; Lo, S. N.; van Akkooi, A. C. J.; Coit, D. G.; Ingvar, C.; Isaksson, K.; Scolyer, R. A.; Thompson, J. F.; more...
    JAMA Surgery (2024)

    Fulltext@MSK | Save
  • Clinical utility of melanoma sentinel lymph node biopsy nomograms
    Journal Article

    Drebin, H. M.; Hosein, S.; Kurtansky, N. R.; Nadelmann, E.; Moy, A. P.; Ariyan, C. E.; Bello, D. M.; Brady, M. S.; Coit, D. G.; Marchetti, M. A.; more...
    Journal of the American College of Surgeons (2024)

    Fulltext@MSK | Save
  • Clinical utility of melanoma sentinel lymph node biopsy nomograms
    Meeting Abstract

    Drebin, H. M.; Hosein, S.; Kurtansky, N.; Moy, A. P.; Ariyan, C. E.; Bello, D. M.; Brady, M. S.; Coit, D. G.; Marchetti, M. A.; Bartlett, E. K.
    Journal of the American College of Surgeons (2023)

    Fulltext@MSK | Save
  • Histologic subvariant predicts outcome in primary retroperitoneal well- differentiated liposarcoma
    Meeting Abstract

    Li, G. Z.; Lee, J.; Whiting, K. A.; Qin, L. X.; Bartlett, E. K.; Crago, A. M.; Brennan, M.; Hameed, M. R.; Singer, S.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical benefit of sentinel lymph node biopsy nomograms for head and neck melanoma
    Meeting Abstract

    Drebin, H. M.; Kurtansky, N. R.; Cracchiolo, J. R.; Marchetti, M. A.; Bartlett, E. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Timing of adjuvant immunotherapy in stage III melanoma, does it matter?
    Meeting Abstract

    Rhodin, K. E.; Jung, S. H.; Elleson, K.; DePalo, D.; Straker, R.; McKinley, S.; Beekman, K.; Parker, L.; Chen, S.; Salama, A.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Timing of adjuvant immunotherapy in stage III melanoma, does it matter?
    Journal Article

    Rhodin, K. E.; Jung, S. H.; Elleson, K.; DePalo, D.; Straker, R.; McKinley, S.; Beekman, K.; Parker, L.; Chen, S.; Iyer, M. K.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Timing of adjuvant immunotherapy in stage III melanoma, does it matter?
    Miscellaneous

    Rhodin, K. E.; Jung, S. H.; Elleson, K.; DePalo, D.; Straker, R.; McKinley, S.; Beekman, K.; Parker, L.; Chen, S.; Iyer, M. K.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save